|
Faculty | |
Statement of Need | |
Activity Goal | |
Learning Objectives | |
Financial Support | |
Target Audience | |
Credit Information |
Alzheimer's Disease: Current Approaches to Practice
neuroscienceCME Multimedia Snack
Premiere Date: Friday, November 30, 2012This activity offers CE credit for:
%>- Physicians (CME)
- Pharmacists (ACPE)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, November 30, 2017
Note: Credit Is No Longer Available
Charles B. Nemeroff, MD, PhD (Moderator) Professor and Chair Department of Psychiatry Mulva Clinic for the Neurosciences Director, Institute of Early Life Adversity Research Dell Medical School The University of Texas at Austin Austin, TX |
Murray A. Raskind, MD, MRM Professor and Vice-Chair, Psychiatry and Behavioral Sciences University of Washington Director, VA Northwest Network (VISN 20) Mental Illness Research Education and Clinical Center (MIRECC) VA Puget Sound Health Care System Seattle, WA |
Evidence-based practice guidelines, such as the American Psychiatric Association’s 2007 Practice Guideline for the Treatment of Patients with Alzheimer’s Disease and Other Dementias, suggest that the strongly support early assessment and intervention.(1) The U. S. Food and Drug Administration approved imaging such as positron emission tomography for Alzheimer’s disease, and this can often inform a diagnosis.(2) In later stages of Alzheimer’s disease, patients experience decreased overall function, have reduced capacity to perform activities of daily living, and frequently exhibit problematic behaviors. Timely assessment and the safe, effective treatment of problematic behavior is always a challenge for the clinician and caregiver.(1)
This neuroscienceCME Snack describes the challenges and limitations of the current management of Alzheimer’s disease and new directions for early assessment and emerging treatments.
- Rabins PV, Blacker D, Rovner BW, et al. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry. 2007;164(12 Suppl):5-56. PMID: 18340692.
- Hyman BT, Phelps CH, Beach TG, et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 2012;8(1):1-13. PMID: 22265587.
Improve early recognition and treatment of Alzheimer’s disease in all clinicians who manage a geriatric population of patients.
At the end of this CE activity, participants should be able to:
- Apply current evidence-based strategies for early identification and treatment of Alzheimer's disease and describe how emerging science can inform clinical practice.
This activity is supported by an educational grant from Elan Pharmaceuticals, Inc. This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Psychiatrists, primary care physicians, neurologists, pharmacists, and other health care professionals who treat patients with Alzheimer’s disease.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .5 contact hours (0.05 CEUs)
Universal Activity Number: 0376-0000-12-028-H01-P (recorded programs)
Activity Type: knowledge-based
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST733 (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
All faculty participating in CME Outfitters continuing education activities are required to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME's Standards for Commercial Support, and other accrediting and regulatory bodies. Full disclosure of faculty relationships will be made on this website and within the activity course materials prior to the premiere date of this activity.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
SN-049-113012-90